BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
543562	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 38.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543563	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 35.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543564	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 130							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543565	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 10300							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543566	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 10.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543567	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 17.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543568	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 27.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543569	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 4340							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543570	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 12.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543571	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 29.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543572	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 51.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543573	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2410							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543574	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 187							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543575	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 380							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543576	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 561							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543577	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>27100							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543578	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 40.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543579	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 89.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543580	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 208							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543581	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>26600							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543582	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 64.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543583	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 49.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543584	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 326							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543585	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 4890							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543586	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 2.77							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543587	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		<1.89							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543588	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2.35							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543589	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 34.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543590	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 20.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543591	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 41.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543592	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 64.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543593	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 5440							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543594	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 3.83							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543595	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 10.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543596	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 40.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543597	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 1490							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543598	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 1.51							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543599	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 3.80							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543600	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 6.84							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543601	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 590							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543602	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12Cl2N4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	HJVCDCPLKNQXFO-UHFFFAOYSA-N	285538	N-cyclopropyl-3-(3,4-di-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 11::US10669279, Example 11::US9598421, Example 11	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 1.60							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285538&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700151	378169177							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543603	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12Cl2N4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	HJVCDCPLKNQXFO-UHFFFAOYSA-N	285538	N-cyclopropyl-3-(3,4-di-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 11::US10669279, Example 11::US9598421, Example 11	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 334							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285538&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700151	378169177							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543604	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 14.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543605	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 35.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543606	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 89.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543607	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 5220							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543608	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 5.13							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543609	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 4.63							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543610	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 17.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543611	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 669							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543612	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 73.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543613	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 79.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543614	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 108							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543615	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>8010							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543616	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 264							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543617	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 252							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543618	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 421							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543619	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>23700							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543620	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-6-18-23)11-4-5-12-17-10-19-22(12)9-11/h1,3-6,9-10H,2,7-8H2	WFFUVTXNYNORQT-UHFFFAOYSA-N	285543	US10077269, Example 16::US10669279, Example 16::US9598421, Example 16::azetidin-1-yl[3-([1,2,4]tri-azolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 552							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285543&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875381	378169182							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543621	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-6-18-23)11-4-5-12-17-10-19-22(12)9-11/h1,3-6,9-10H,2,7-8H2	WFFUVTXNYNORQT-UHFFFAOYSA-N	285543	US10077269, Example 16::US10669279, Example 16::US9598421, Example 16::azetidin-1-yl[3-([1,2,4]tri-azolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>27500							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285543&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875381	378169182							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543622	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 89.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543623	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 175							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543624	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 216							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543625	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>18200							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543626	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 55.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543627	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 150							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543628	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 147							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543629	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 8200							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543630	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 16.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543631	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 13.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543632	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 98.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543633	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 645							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543634	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 6.70							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543635	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 5.74							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543636	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 74.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543637	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 490							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543638	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 53.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543639	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 91.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543640	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 170							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543641	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>12300							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543642	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 27.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543643	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 58.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543644	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 71.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543645	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 1890							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543646	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 15.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543647	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 30.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543648	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 45.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543649	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 4130							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543650	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 5.04							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543651	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 19.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543652	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 59.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543653	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>2150							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543654	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 38.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543655	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 140							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543656	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 150							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543657	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 4970							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543658	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 85.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543659	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 114							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543660	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 111							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543661	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3800							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543662	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 742							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543663	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 609							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543664	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 768							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543665	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 5620							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543666	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 15.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543667	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 31.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543668	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 49.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543669	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 393							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543670	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 3.48							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543671	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 5.05							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543672	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 13.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543673	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 409							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543674	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 11.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543675	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 55.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543676	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 24.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543677	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 4000							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543678	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 2820							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543679	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 2670							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543680	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 5810							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543681	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>26200							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543682	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 1030							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543683	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 419							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543684	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 469							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543685	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>30000							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543686	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 58.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543687	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 53.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543688	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 127							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543689	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2330							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543690	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 29.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543691	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 83.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543692	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 47.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543693	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2110							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543694	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 35.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543695	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 48.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543696	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 37.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543697	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 1220							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543698	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 23.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543699	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 6.99							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543700	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 21.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543701	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 254							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543702	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 127							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543703	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 75.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543704	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 161							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543705	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2570							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543706	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-3-4-11)15-16(22-14(21-15)2-1-6-19-22)10-8-13-12(18-9-10)5-7-24-13/h1-2,5-9,11H,3-4H2,(H,20,23)	XQQOHFBKZLHZIC-UHFFFAOYSA-N	285565	N-cyclopropyl-3-(furo[3,2-b]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 38::US10669279, Example 38::US9598421, Example 38	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 268							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285565&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700168	378169204							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543707	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-3-4-11)15-16(22-14(21-15)2-1-6-19-22)10-8-13-12(18-9-10)5-7-24-13/h1-2,5-9,11H,3-4H2,(H,20,23)	XQQOHFBKZLHZIC-UHFFFAOYSA-N	285565	N-cyclopropyl-3-(furo[3,2-b]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 38::US10669279, Example 38::US9598421, Example 38	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 11200							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285565&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700168	378169204							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543708	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 14.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543709	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 26.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543710	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 67.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543711	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3820							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543712	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 19.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543713	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 65.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543714	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 58.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543715	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 9020							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543716	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 3.13							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543717	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 8.05							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543718	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 16.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543719	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 467							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543720	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 415							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543721	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 393							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543722	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 357							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543723	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>12200							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543724	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-9-10(4-6-20-11)14-13(15(25)23-7-2-8-23)22-12-3-1-5-21-24(12)14/h1,3-6,9H,2,7-8H2	GXXYJNKWPOFUGD-UHFFFAOYSA-N	285570	US10077269, Example 43::US10669279, Example 43::US9598421, Example 43::azetidin-1-yl{3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 270							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285570&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875413	378169209							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543725	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-9-10(4-6-20-11)14-13(15(25)23-7-2-8-23)22-12-3-1-5-21-24(12)14/h1,3-6,9H,2,7-8H2	GXXYJNKWPOFUGD-UHFFFAOYSA-N	285570	US10077269, Example 43::US10669279, Example 43::US9598421, Example 43::azetidin-1-yl{3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>16900							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285570&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875413	378169209							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543726	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1(F)F	InChI=1S/C16H10ClF3N4O/c17-9-4-3-8(6-10(9)18)14-13(15(25)22-11-7-16(11,19)20)23-12-2-1-5-21-24(12)14/h1-6,11H,7H2,(H,22,25)	LLYJCFVFPOZAJN-UHFFFAOYSA-N	285571	3-(4-chloro-3-fluorophenyl)-N-(2,2-difluorocyclopro-pyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 44::US10669279, Example 44::US9598421, Example 44	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 3.92							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285571&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875387	378169210							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543727	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1(F)F	InChI=1S/C16H10ClF3N4O/c17-9-4-3-8(6-10(9)18)14-13(15(25)22-11-7-16(11,19)20)23-12-2-1-5-21-24(12)14/h1-6,11H,7H2,(H,22,25)	LLYJCFVFPOZAJN-UHFFFAOYSA-N	285571	3-(4-chloro-3-fluorophenyl)-N-(2,2-difluorocyclopro-pyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 44::US10669279, Example 44::US9598421, Example 44	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 320							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285571&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875387	378169210							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543728	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 2.91							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543729	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 1.97							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543730	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 11.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543731	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 159							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543732	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 15.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543733	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 12.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543734	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 39.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543735	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 971							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543736	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 7.37							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543737	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 3.90							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543738	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 23.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543739	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 334							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543740	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 768							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543741	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 322							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543742	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 212							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543743	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>7670							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543744	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 4.16							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543745	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 13.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543746	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 19.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543747	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 535							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543748	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 28.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543749	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 116							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543750	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 235							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543751	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3140							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543752	Cc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(5-6-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	TZEKFEDRWKCDSN-UHFFFAOYSA-N	285578	US10077269, Example 51::US10669279, Example 51::US9598421, Example 51::azetidin-1-yl[3-(4-chloro-3-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 42.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285578&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700177	378169217							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543753	Cc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(5-6-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	TZEKFEDRWKCDSN-UHFFFAOYSA-N	285578	US10077269, Example 51::US10669279, Example 51::US9598421, Example 51::azetidin-1-yl[3-(4-chloro-3-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2810							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285578&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700177	378169217							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543754	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 24.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543755	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 37.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543756	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 113							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543757	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 5510							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543758	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 17.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543759	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 63.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543760	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 153							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543761	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3110							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543762	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 103							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543763	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 107							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543764	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 136							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543765	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>20000							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543766	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 176							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543767	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 200							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543768	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>1550							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543769	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>20900							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543770	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 22.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543771	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 43.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543772	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 84.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543773	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3930							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543774	Oc1ccccc1CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C21H17ClN4O2/c22-16-9-7-15(8-10-16)20-19(25-18-6-3-12-24-26(18)20)21(28)23-13-11-14-4-1-2-5-17(14)27/h1-10,12,27H,11,13H2,(H,23,28)	AQSPRZIQVZXKMZ-UHFFFAOYSA-N	285584	3-(4-chlorophenyl)-N-[2-(2-hydroxyphenyl)ethyl]imidazo[1,2-b]pyridazine-2-carboxamide,formate salt::US10077269, Example 57::US10669279, Example 57::US9598421, Example 57	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 236							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285584&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700182	378169223							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543775	Oc1ccccc1CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C21H17ClN4O2/c22-16-9-7-15(8-10-16)20-19(25-18-6-3-12-24-26(18)20)21(28)23-13-11-14-4-1-2-5-17(14)27/h1-10,12,27H,11,13H2,(H,23,28)	AQSPRZIQVZXKMZ-UHFFFAOYSA-N	285584	3-(4-chlorophenyl)-N-[2-(2-hydroxyphenyl)ethyl]imidazo[1,2-b]pyridazine-2-carboxamide,formate salt::US10077269, Example 57::US10669279, Example 57::US9598421, Example 57	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>21800							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285584&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700182	378169223							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543776	Cc1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)no1	InChI=1S/C17H12ClN5O2/c1-10-9-13(22-25-10)20-17(24)15-16(11-4-6-12(18)7-5-11)23-14(21-15)3-2-8-19-23/h2-9H,1H3,(H,20,22,24)	WFHCBSIMFWEHOP-UHFFFAOYSA-N	285585	3-(4-chlorophenyl)-N-(5-methyl-1,2-oxazol-3-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 58::US10669279, Example 58::US9598421, Example 58	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 43.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285585&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700183	378169224							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543777	Cc1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)no1	InChI=1S/C17H12ClN5O2/c1-10-9-13(22-25-10)20-17(24)15-16(11-4-6-12(18)7-5-11)23-14(21-15)3-2-8-19-23/h2-9H,1H3,(H,20,22,24)	WFHCBSIMFWEHOP-UHFFFAOYSA-N	285585	3-(4-chlorophenyl)-N-(5-methyl-1,2-oxazol-3-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 58::US10669279, Example 58::US9598421, Example 58	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 831							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285585&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700183	378169224							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543778	Cn1ncc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)n1	InChI=1S/C16H12ClN7O/c1-23-19-9-12(22-23)20-16(25)14-15(10-4-6-11(17)7-5-10)24-13(21-14)3-2-8-18-24/h2-9H,1H3,(H,20,22,25)	KUCAVVPPPHKSFZ-UHFFFAOYSA-N	285586	3-(4-chlorophenyl)-N-(2-methyl-2H-1,2,3-triazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 59::US10669279, Example 59::US9598421, Example 59	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 58.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285586&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700184	378169225							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543779	Cn1ncc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)n1	InChI=1S/C16H12ClN7O/c1-23-19-9-12(22-23)20-16(25)14-15(10-4-6-11(17)7-5-10)24-13(21-14)3-2-8-18-24/h2-9H,1H3,(H,20,22,25)	KUCAVVPPPHKSFZ-UHFFFAOYSA-N	285586	3-(4-chlorophenyl)-N-(2-methyl-2H-1,2,3-triazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 59::US10669279, Example 59::US9598421, Example 59	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 749							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285586&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700184	378169225							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543780	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 269							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543781	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 196							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543782	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 287							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543783	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>4930							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543784	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 144							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543785	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 184							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543786	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 126							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543787	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 1930							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543788	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2nccnc2c1	InChI=1S/C18H14N6O/c25-18(23-9-2-10-23)16-17(24-15(22-16)3-1-6-21-24)12-4-5-13-14(11-12)20-8-7-19-13/h1,3-8,11H,2,9-10H2	BGLGXXOVOLTBJL-UHFFFAOYSA-N	285589	US10077269, Example 62::US10669279, Example 62::US9598421, Example 62::azetidin-1-yl[3-(quinoxalin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone, formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 275							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285589&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700187	378169228							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543789	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2nccnc2c1	InChI=1S/C18H14N6O/c25-18(23-9-2-10-23)16-17(24-15(22-16)3-1-6-21-24)12-4-5-13-14(11-12)20-8-7-19-13/h1,3-8,11H,2,9-10H2	BGLGXXOVOLTBJL-UHFFFAOYSA-N	285589	US10077269, Example 62::US10669279, Example 62::US9598421, Example 62::azetidin-1-yl[3-(quinoxalin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone, formate salt	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 11000							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285589&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700187	378169228							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543790	CC(=O)c1ccc(F)c(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H15FN4O2/c1-11(24)12-5-6-14(19)13(10-12)17-16(18(25)22-8-3-9-22)21-15-4-2-7-20-23(15)17/h2,4-7,10H,3,8-9H2,1H3	QERGAMABSQIOLR-UHFFFAOYSA-N	285590	1-{3-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-4-fluoro-phenyl}ethanone, formate salt::US10077269, Example 63::US10669279, Example 63::US9598421, Example 63	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 17.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285590&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875365	378169229							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543791	CC(=O)c1ccc(F)c(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H15FN4O2/c1-11(24)12-5-6-14(19)13(10-12)17-16(18(25)22-8-3-9-22)21-15-4-2-7-20-23(15)17/h2,4-7,10H,3,8-9H2,1H3	QERGAMABSQIOLR-UHFFFAOYSA-N	285590	1-{3-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-4-fluoro-phenyl}ethanone, formate salt::US10077269, Example 63::US10669279, Example 63::US9598421, Example 63	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 394							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285590&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875365	378169229							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543792	Cc1ccc(Cl)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(18)10-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	COVWSPFRFUFHGD-UHFFFAOYSA-N	285591	US10077269, Example 64::US10669279, Example 64::US9598421, Example 64::azetidin-1-yl[3-(5-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 24.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285591&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700189	378169230							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543793	Cc1ccc(Cl)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(18)10-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	COVWSPFRFUFHGD-UHFFFAOYSA-N	285591	US10077269, Example 64::US10669279, Example 64::US9598421, Example 64::azetidin-1-yl[3-(5-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 844							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285591&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700189	378169230							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543794	Clc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(Cl)c1	InChI=1S/C16H12Cl2N4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	HDPIQIDAUQGIBP-UHFFFAOYSA-N	285592	US10077269, Example 65::US10669279, Example 65::US9598421, Example 65::azetidin-1-yl[3-(2,4-dichlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 71.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285592&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700188	378169231							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543795	Clc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(Cl)c1	InChI=1S/C16H12Cl2N4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	HDPIQIDAUQGIBP-UHFFFAOYSA-N	285592	US10077269, Example 65::US10669279, Example 65::US9598421, Example 65::azetidin-1-yl[3-(2,4-dichlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3720							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285592&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700188	378169231							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543796	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(C)c1Cl	InChI=1S/C18H17ClN4O/c1-11-6-7-13(12(2)15(11)19)17-16(18(24)22-9-4-10-22)21-14-5-3-8-20-23(14)17/h3,5-8H,4,9-10H2,1-2H3	FQEXMVRMBJXJHA-UHFFFAOYSA-N	285593	US10077269, Example 66::US10669279, Example 66::US9598421, Example 66::azetidin-1-yl[3-(3-chloro-2,4-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 41.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285593&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700190	378169232							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543797	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(C)c1Cl	InChI=1S/C18H17ClN4O/c1-11-6-7-13(12(2)15(11)19)17-16(18(24)22-9-4-10-22)21-14-5-3-8-20-23(14)17/h3,5-8H,4,9-10H2,1-2H3	FQEXMVRMBJXJHA-UHFFFAOYSA-N	285593	US10077269, Example 66::US10669279, Example 66::US9598421, Example 66::azetidin-1-yl[3-(3-chloro-2,4-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3390							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285593&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700190	378169232							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543798	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCOc2c1	InChI=1S/C18H16N4O3/c23-18(21-7-2-8-21)16-17(22-15(20-16)3-1-6-19-22)12-4-5-13-14(11-12)25-10-9-24-13/h1,3-6,11H,2,7-10H2	KQJWGLFCGGXBHN-UHFFFAOYSA-N	285594	US10077269, Example 67::US10669279, Example 67::US9598421, Example 67::azetidin-1-yl[3-(2,3-dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 59.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285594&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875392	378169233							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543799	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCOc2c1	InChI=1S/C18H16N4O3/c23-18(21-7-2-8-21)16-17(22-15(20-16)3-1-6-19-22)12-4-5-13-14(11-12)25-10-9-24-13/h1,3-6,11H,2,7-10H2	KQJWGLFCGGXBHN-UHFFFAOYSA-N	285594	US10077269, Example 67::US10669279, Example 67::US9598421, Example 67::azetidin-1-yl[3-(2,3-dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2260							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285594&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875392	378169233							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543800	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 10.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543801	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 35.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543802	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 25.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543803	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2620							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543804	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H11ClFN5O/c16-9-4-8(6-18-7-9)14-13(15(23)20-11-5-10(11)17)21-12-2-1-3-19-22(12)14/h1-4,6-7,10-11H,5H2,(H,20,23)/t10-,11+/m0/s1	ZHXHNZIKCBDMKP-WDEREUQCSA-N	285596	3-(5-chloropyridin-3-yl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 69::US10669279, Example 69::US9598421, Example 69	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 116							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285596&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700193	378169235							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543805	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H11ClFN5O/c16-9-4-8(6-18-7-9)14-13(15(23)20-11-5-10(11)17)21-12-2-1-3-19-22(12)14/h1-4,6-7,10-11H,5H2,(H,20,23)/t10-,11+/m0/s1	ZHXHNZIKCBDMKP-WDEREUQCSA-N	285596	3-(5-chloropyridin-3-yl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 69::US10669279, Example 69::US9598421, Example 69	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3330							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285596&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700193	378169235							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543806	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 36.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543807	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 31.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543808	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 90.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543809	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 5760							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543810	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		<0.669							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543811	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 2.82							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543812	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2.00							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543813	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 113							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543814	Cc1ccc(-c2c(nc3cccnn23)C(=O)N[C@@H]2C[C@@H]2F)c(F)c1	InChI=1S/C17H14F2N4O/c1-9-4-5-10(11(18)7-9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	LTEXTCILPHUJPK-QWHCGFSZSA-N	285599	N-[(1R,2S)-2-fluorocyclopro-pyl]-3-(2-fluoro-4-methyl-phenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 72::US10669279, Example 72::US9598421, Example 72	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 192							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285599&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700195	378169238							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543815	Cc1ccc(-c2c(nc3cccnn23)C(=O)N[C@@H]2C[C@@H]2F)c(F)c1	InChI=1S/C17H14F2N4O/c1-9-4-5-10(11(18)7-9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	LTEXTCILPHUJPK-QWHCGFSZSA-N	285599	N-[(1R,2S)-2-fluorocyclopro-pyl]-3-(2-fluoro-4-methyl-phenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 72::US10669279, Example 72::US9598421, Example 72	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 6590							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285599&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700195	378169238							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543816	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 165							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543817	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 495							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543818	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 1440							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543819	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>24700							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543820	O=C(N1CCC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-5-19-23)11-9-17-12-4-6-18-22(12)10-11/h1,3-6,9-10H,2,7-8H2	RINAWWCARFNGLM-UHFFFAOYSA-N	285601	US10077269, Example 74::US10669279, Example 74::US9598421, Example 74::azetidin-1-yl[3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 225							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285601&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700198	378169240							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3D3P,3FRG,3G45,3GWT,3HMV,3O56,3O57,5LAQ,5OHJ,8OEG	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543821	O=C(N1CCC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-5-19-23)11-9-17-12-4-6-18-22(12)10-11/h1,3-6,9-10H,2,7-8H2	RINAWWCARFNGLM-UHFFFAOYSA-N	285601	US10077269, Example 74::US10669279, Example 74::US9598421, Example 74::azetidin-1-yl[3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 10500							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285601&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700198	378169240							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543822	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 75::US10669279, Example 75::US9598421, Example 75	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 10.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543823	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	US10077269, Example 75::N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 75::US10669279, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 5.99							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543824	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	US10077269, Example 75::N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 75::US10669279, Example 75	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 24.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543825	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	US10077269, Example 75::N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 75::US10669279, Example 75	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 104							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543826	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 76::US10669279, Example 76	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 7.09							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543827	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 76::US10669279, Example 76	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 5.43							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543828	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 76::US10669279, Example 76	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 22.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543829	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 76::US10669279, Example 76	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 94.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543830	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 77::US10669279, Example 77	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 46.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543831	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 77::US10669279, Example 77	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 80.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543832	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 77::US10669279, Example 77	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 186							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543833	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 77::US10669279, Example 77	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>16600							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543834	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-3-4-11)14-15(23-13(21-14)2-1-6-19-23)10-8-17-12-5-7-18-22(12)9-10/h1-2,5-9,11H,3-4H2,(H,20,24)	CWHUSRYDJYDLGV-UHFFFAOYSA-N	285608	US10077269, Example 78::N-cyclopropyl-3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 78::US10669279, Example 78	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 364							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285608	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285608&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875395	378169247							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543835	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-3-4-11)14-15(23-13(21-14)2-1-6-19-23)10-8-17-12-5-7-18-22(12)9-10/h1-2,5-9,11H,3-4H2,(H,20,24)	CWHUSRYDJYDLGV-UHFFFAOYSA-N	285608	US10077269, Example 78::N-cyclopropyl-3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 78::US10669279, Example 78	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 6490							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285608	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285608&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875395	378169247							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543836	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,.13,;-1.67,.53,;-1.27,2.02,;.21,2.51,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	US10077269, Example 79::3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 79::US10669279, Example 79	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 48.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543837	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,.13,;-1.67,.53,;-1.27,2.02,;.21,2.51,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	US10077269, Example 79::3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 79::US10669279, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 190							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543838	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,.13,;-1.67,.53,;-1.27,2.02,;.21,2.51,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	US10077269, Example 79::3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 79::US10669279, Example 79	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 297							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543839	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,.13,;-1.67,.53,;-1.27,2.02,;.21,2.51,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	US10077269, Example 79::3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 79::US10669279, Example 79	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>25400							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543840	Cc1ccc(cc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,1.62,;-1.67,2.02,;-1.27,3.51,;.22,3.91,;1.43,2.84,;.91,1.33,;-.58,.93,;-.98,-.56,;-.07,-1.8,;-.98,-3.05,;-2.44,-2.57,;-3.78,-3.34,;-5.11,-2.57,;-5.11,-1.03,;-3.78,-.26,;-2.44,-1.03,;1.47,-1.8,;2.24,-.47,;2.24,-3.14,;3.78,-3.14,;5.11,-3.91,;5.11,-2.37,;2.92,3.23,;4.41,3.63,)|	InChI=1S/C18H15N5O/c1-11-4-5-12(10-19)9-14(11)17-16(18(24)21-13-6-7-13)22-15-3-2-8-20-23(15)17/h2-5,8-9,13H,6-7H2,1H3,(H,21,24)	AYAPJFYFCDHLKN-UHFFFAOYSA-N	285610	US10077269, Example 80::3-(5-cyano-2-methylphenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 80::US10669279, Example 80	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 344							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285610	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285610&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875393	378169249							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543841	Cc1ccc(cc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,1.62,;-1.67,2.02,;-1.27,3.51,;.22,3.91,;1.43,2.84,;.91,1.33,;-.58,.93,;-.98,-.56,;-.07,-1.8,;-.98,-3.05,;-2.44,-2.57,;-3.78,-3.34,;-5.11,-2.57,;-5.11,-1.03,;-3.78,-.26,;-2.44,-1.03,;1.47,-1.8,;2.24,-.47,;2.24,-3.14,;3.78,-3.14,;5.11,-3.91,;5.11,-2.37,;2.92,3.23,;4.41,3.63,)|	InChI=1S/C18H15N5O/c1-11-4-5-12(10-19)9-14(11)17-16(18(24)21-13-6-7-13)22-15-3-2-8-20-23(15)17/h2-5,8-9,13H,6-7H2,1H3,(H,21,24)	AYAPJFYFCDHLKN-UHFFFAOYSA-N	285610	US10077269, Example 80::3-(5-cyano-2-methylphenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 80::US10669279, Example 80	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>25400							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285610	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285610&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875393	378169249							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543842	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	US10077269, Example 81::3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 81::US10669279, Example 81	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 7.86							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543843	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	US10077269, Example 81::3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 81::US10669279, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 9.34							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543844	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	US10077269, Example 81::3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 81::US10669279, Example 81	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 25.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543845	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	US10077269, Example 81::3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 81::US10669279, Example 81	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 853							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543846	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	US10077269, Example 82::3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 82::US10669279, Example 82	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 12.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543847	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	US10077269, Example 82::3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 82::US10669279, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 5.14							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543848	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	US10077269, Example 82::3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 82::US10669279, Example 82	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 43.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543849	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	US10077269, Example 82::3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 82::US10669279, Example 82	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 56.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543850	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 83::US10669279, Example 83	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 6.21							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543851	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 83::US10669279, Example 83	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 5.39							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543852	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 83::US10669279, Example 83	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 40.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543853	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 83::US10669279, Example 83	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 495							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543854	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 84::US10669279, Example 84	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 16.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543855	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 84::US10669279, Example 84	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 7.84							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543856	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 84::US10669279, Example 84	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 44.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543857	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 84::US10669279, Example 84	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 977							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543858	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	US10077269, Example 85::3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 85::US10669279, Example 85	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 25.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543859	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	US10077269, Example 85::3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 85::US10669279, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 87.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543860	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	US10077269, Example 85::3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 85::US10669279, Example 85	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 47.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543861	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	US10077269, Example 85::3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 85::US10669279, Example 85	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 6700							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543862	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 86::US10669279, Example 86	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 5.83							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543863	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 86::US10669279, Example 86	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 7.72							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543864	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 86::US10669279, Example 86	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 25.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543865	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 86::US10669279, Example 86	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 179							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543866	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	US10077269, Example 87::N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 87::US10669279, Example 87	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 240							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543867	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	US10077269, Example 87::N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 87::US10669279, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 173							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543868	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	US10077269, Example 87::N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 87::US10669279, Example 87	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 397							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543869	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	US10077269, Example 87::N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 87::US10669279, Example 87	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 6790							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543870	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	US10077269, Example 88::3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 88::US10669279, Example 88	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 45.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543871	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	US10077269, Example 88::3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 88::US10669279, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 39.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543872	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	US10077269, Example 88::3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 88::US10669279, Example 88	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 136							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543873	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	US10077269, Example 88::3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 88::US10669279, Example 88	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 10400							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543874	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.94,;-1.67,1.33,;-1.27,2.82,;.22,3.22,;.92,4.59,;2.44,4.35,;2.68,2.83,;1.31,2.13,;.91,.64,;-.58,.24,;-.98,-1.24,;-.07,-2.49,;-.98,-3.73,;-2.44,-3.26,;-3.78,-4.03,;-5.11,-3.26,;-5.11,-1.72,;-3.78,-.95,;-2.44,-1.72,;1.47,-2.49,;2.24,-1.15,;2.24,-3.82,;3.78,-3.82,;5.11,-4.59,;5.11,-3.05,)|	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	US10077269, Example 89::N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 89::US10669279, Example 89	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 829							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543875	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.94,;-1.67,1.33,;-1.27,2.82,;.22,3.22,;.92,4.59,;2.44,4.35,;2.68,2.83,;1.31,2.13,;.91,.64,;-.58,.24,;-.98,-1.24,;-.07,-2.49,;-.98,-3.73,;-2.44,-3.26,;-3.78,-4.03,;-5.11,-3.26,;-5.11,-1.72,;-3.78,-.95,;-2.44,-1.72,;1.47,-2.49,;2.24,-1.15,;2.24,-3.82,;3.78,-3.82,;5.11,-4.59,;5.11,-3.05,)|	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	US10077269, Example 89::N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 89::US10669279, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 333							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543876	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.94,;-1.67,1.33,;-1.27,2.82,;.22,3.22,;.92,4.59,;2.44,4.35,;2.68,2.83,;1.31,2.13,;.91,.64,;-.58,.24,;-.98,-1.24,;-.07,-2.49,;-.98,-3.73,;-2.44,-3.26,;-3.78,-4.03,;-5.11,-3.26,;-5.11,-1.72,;-3.78,-.95,;-2.44,-1.72,;1.47,-2.49,;2.24,-1.15,;2.24,-3.82,;3.78,-3.82,;5.11,-4.59,;5.11,-3.05,)|	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	US10077269, Example 89::N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 89::US10669279, Example 89	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3760							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543877	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.94,;-1.67,1.33,;-1.27,2.82,;.22,3.22,;.92,4.59,;2.44,4.35,;2.68,2.83,;1.31,2.13,;.91,.64,;-.58,.24,;-.98,-1.24,;-.07,-2.49,;-.98,-3.73,;-2.44,-3.26,;-3.78,-4.03,;-5.11,-3.26,;-5.11,-1.72,;-3.78,-.95,;-2.44,-1.72,;1.47,-2.49,;2.24,-1.15,;2.24,-3.82,;3.78,-3.82,;5.11,-4.59,;5.11,-3.05,)|	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	US10077269, Example 89::N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 89::US10669279, Example 89	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>17200							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543878	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	US10077269, Example 90::3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 90::US10669279, Example 90	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 21.4							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543879	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	US10077269, Example 90::3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 90::US10669279, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 43.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543880	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	US10077269, Example 90::3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 90::US10669279, Example 90	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 25.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543881	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	US10077269, Example 90::3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 90::US10669279, Example 90	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2620							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543882	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl |(3.49,3.03,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,;.91,3.72,;1.31,5.21,)|	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 91::US10669279, Example 91	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 12.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543883	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl |(3.49,3.03,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,;.91,3.72,;1.31,5.21,)|	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 91::US10669279, Example 91	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 36.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543884	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl |(3.49,3.03,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,;.91,3.72,;1.31,5.21,)|	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 91::US10669279, Example 91	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 80.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543885	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl |(3.49,3.03,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,;.91,3.72,;1.31,5.21,)|	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 91::US10669279, Example 91	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 2250							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543886	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(2.79,1.73,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;-1.67,.53,;-3.16,.13,;-1.27,2.02,;.21,2.51,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	US10077269, Example 92::3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 92::US10669279, Example 92	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 5.52							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543887	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(2.79,1.73,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;-1.67,.53,;-3.16,.13,;-1.27,2.02,;.21,2.51,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	US10077269, Example 92::3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 92::US10669279, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 21.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543888	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(2.79,1.73,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;-1.67,.53,;-3.16,.13,;-1.27,2.02,;.21,2.51,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	US10077269, Example 92::3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 92::US10669279, Example 92	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 42.5							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543889	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(2.79,1.73,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;-1.67,.53,;-3.16,.13,;-1.27,2.02,;.21,2.51,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	US10077269, Example 92::3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 92::US10669279, Example 92	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>1440							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543890	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.44,-4.16,;2.9,-4.16,;2.13,-2.83,;2.9,-1.49,;.59,-2.83,;-.31,-4.07,;-1.78,-3.6,;-3.11,-4.37,;-4.44,-3.6,;-4.44,-2.06,;-3.11,-1.29,;-1.78,-2.06,;-.31,-1.58,;.09,-.09,;1.57,.3,;1.97,1.79,;3.46,2.19,;.88,2.88,;1.28,4.37,;-.6,2.48,;-1,.99,;-2.49,.6,)|	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	US10077269, Example 93::3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 93::US10669279, Example 93	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 62.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543891	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.44,-4.16,;2.9,-4.16,;2.13,-2.83,;2.9,-1.49,;.59,-2.83,;-.31,-4.07,;-1.78,-3.6,;-3.11,-4.37,;-4.44,-3.6,;-4.44,-2.06,;-3.11,-1.29,;-1.78,-2.06,;-.31,-1.58,;.09,-.09,;1.57,.3,;1.97,1.79,;3.46,2.19,;.88,2.88,;1.28,4.37,;-.6,2.48,;-1,.99,;-2.49,.6,)|	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	US10077269, Example 93::3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 93::US10669279, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 276							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543892	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.44,-4.16,;2.9,-4.16,;2.13,-2.83,;2.9,-1.49,;.59,-2.83,;-.31,-4.07,;-1.78,-3.6,;-3.11,-4.37,;-4.44,-3.6,;-4.44,-2.06,;-3.11,-1.29,;-1.78,-2.06,;-.31,-1.58,;.09,-.09,;1.57,.3,;1.97,1.79,;3.46,2.19,;.88,2.88,;1.28,4.37,;-.6,2.48,;-1,.99,;-2.49,.6,)|	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	US10077269, Example 93::3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 93::US10669279, Example 93	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 134							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543893	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.44,-4.16,;2.9,-4.16,;2.13,-2.83,;2.9,-1.49,;.59,-2.83,;-.31,-4.07,;-1.78,-3.6,;-3.11,-4.37,;-4.44,-3.6,;-4.44,-2.06,;-3.11,-1.29,;-1.78,-2.06,;-.31,-1.58,;.09,-.09,;1.57,.3,;1.97,1.79,;3.46,2.19,;.88,2.88,;1.28,4.37,;-.6,2.48,;-1,.99,;-2.49,.6,)|	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	US10077269, Example 93::3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 93::US10669279, Example 93	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 4110							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543894	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	US10077269, Example 94::3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 94::US10669279, Example 94	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 24.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543895	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	US10077269, Example 94::3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 94::US10669279, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 253							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543896	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	US10077269, Example 94::3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 94::US10669279, Example 94	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 65.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543897	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	US10077269, Example 94::3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 94::US10669279, Example 94	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 5380							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543898	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1C |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C16H15ClN4O/c1-3-18-16(22)14-15(12-7-6-11(17)9-10(12)2)21-13(20-14)5-4-8-19-21/h4-9H,3H2,1-2H3,(H,18,22)	HRLMOSFOSQNGMI-UHFFFAOYSA-N	285625	US10077269, Example 95::3-(4-chloro-2-methylphenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 95::US10669279, Example 95	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 306							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285625	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285625&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875368	378169264							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543899	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1C |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C16H15ClN4O/c1-3-18-16(22)14-15(12-7-6-11(17)9-10(12)2)21-13(20-14)5-4-8-19-21/h4-9H,3H2,1-2H3,(H,18,22)	HRLMOSFOSQNGMI-UHFFFAOYSA-N	285625	US10077269, Example 95::3-(4-chloro-2-methylphenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 95::US10669279, Example 95	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 14800							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285625	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285625&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875368	378169264							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543900	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	US10077269, Example 96::3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 96::US10669279, Example 96	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 4.58							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543901	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	US10077269, Example 96::3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 96::US10669279, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 33.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543902	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	US10077269, Example 96::3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 96::US10669279, Example 96	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 29.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543903	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	US10077269, Example 96::3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 96::US10669279, Example 96	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 908							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543904	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(4.83,-2.26,;4.06,-3.6,;4.83,-4.93,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	US10077269, Example 97::3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 97::US10669279, Example 97	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 5.48							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543905	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(4.83,-2.26,;4.06,-3.6,;4.83,-4.93,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	US10077269, Example 97::3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 97::US10669279, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 23.3							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543906	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(4.83,-2.26,;4.06,-3.6,;4.83,-4.93,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	US10077269, Example 97::3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 97::US10669279, Example 97	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 20.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543907	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(4.83,-2.26,;4.06,-3.6,;4.83,-4.93,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	US10077269, Example 97::3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 97::US10669279, Example 97	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>1850							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543908	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	US10077269, Example 98::3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 98::US10669279, Example 98	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 26.6							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543909	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	US10077269, Example 98::3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 98::US10669279, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 62.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543910	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	US10077269, Example 98::3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 98::US10669279, Example 98	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 107							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543911	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	US10077269, Example 98::3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 98::US10669279, Example 98	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 3320							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543912	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	US10077269, Example 99::3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 99::US10669279, Example 99	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 19.8							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543913	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	US10077269, Example 99::3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 99::US10669279, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 36.2							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543914	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	US10077269, Example 99::3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 99::US10669279, Example 99	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 138							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543915	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	US10077269, Example 99::3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 99::US10669279, Example 99	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 1550							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543916	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;4.83,-2.26,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C16H13ClF2N4O/c1-8(2)21-16(24)14-15(23-13(22-14)4-3-5-20-23)9-6-12(19)10(17)7-11(9)18/h3-8H,1-2H3,(H,21,24)	JMTGAAJHYHUEQI-UHFFFAOYSA-N	285630	US10077269, Example 100::3-(4-chloro-2,5-difluoro-phenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 100::US10669279, Example 100	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 49.1							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285630	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285630&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700207	378169269							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543917	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;4.83,-2.26,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C16H13ClF2N4O/c1-8(2)21-16(24)14-15(23-13(22-14)4-3-5-20-23)9-6-12(19)10(17)7-11(9)18/h3-8H,1-2H3,(H,21,24)	JMTGAAJHYHUEQI-UHFFFAOYSA-N	285630	US10077269, Example 100::3-(4-chloro-2,5-difluoro-phenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 100::US10669279, Example 100	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 766							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285630	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285630&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700207	378169269							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543918	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	US10077269, Example 101::3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 101::US10669279, Example 101	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 268							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543919	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	US10077269, Example 101::3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 101::US10669279, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 861							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543920	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	US10077269, Example 101::3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 101::US10669279, Example 101	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 1179							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543921	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	US10077269, Example 101::3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 101::US10669279, Example 101	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		>25900							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543922	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	US10077269, Example 102::3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 102::US10669279, Example 102	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 59.9							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543923	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	US10077269, Example 102::3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 102::US10669279, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 103							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543924	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	US10077269, Example 102::3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 102::US10669279, Example 102	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 76.0							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543925	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	US10077269, Example 102::3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 102::US10669279, Example 102	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 5010							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543926	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	US10077269, Example 103::3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 103::US10669279, Example 103	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		 62.7							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543927	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	US10077269, Example 103::3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 103::US10669279, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 249							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543928	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	US10077269, Example 103::3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 103::US10669279, Example 103	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 203							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543929	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	US10077269, Example 103::3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 103::US10669279, Example 103	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 1550							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543930	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	US10077269, Example 104::3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 104::US10669279, Example 104	Isoform 4 of cAMP-specific 3',5'-cyclic phosphodiesterase 4A (RD1)	Human		<0.488							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=471&target=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=Isoform+4+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%28RD1%29&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MPLVDFFCETCSKPWLVGWWDQFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543931	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	US10077269, Example 104::3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 104::US10669279, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736,S654A]	Human		 1.59							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=472&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%2CS654A%5D&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	ATFPGHSQRREEFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3HMV,3O57,3O56,3GWT,3FRG,3D3P,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U,5K32	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543932	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	US10077269, Example 104::3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 104::US10669279, Example 104	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 4.69							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
543933	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	US10077269, Example 104::3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 104::US10669279, Example 104	Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3)	Human		 145							US Patent		10.7270/Q2P84DX5		aid1795686	US10077269	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	9/18/2018	1/11/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7